Cite
HYpofractionated, dose-redistributed RAdiotherapy with protons and photons to combat radiation-induced immunosuppression in head and neck squamous cell carcinoma: study protocol of the phase I HYDRA trial.
MLA
Elbers, Joris B. W., et al. “HYpofractionated, Dose-Redistributed RAdiotherapy with Protons and Photons to Combat Radiation-Induced Immunosuppression in Head and Neck Squamous Cell Carcinoma: Study Protocol of the Phase I HYDRA Trial.” BMC Cancer, vol. 23, no. 1, June 2023, pp. 1–8. EBSCOhost, https://doi.org/10.1186/s12885-023-11031-w.
APA
Elbers, J. B. W., Gunsch, P. A., Debets, R., Keereweer, S., van Meerten, E., Zindler, J., van Norden, Y., Hoogeman, M. S., Verduijn, G. M., Kroesen, M., & Nout, R. A. (2023). HYpofractionated, dose-redistributed RAdiotherapy with protons and photons to combat radiation-induced immunosuppression in head and neck squamous cell carcinoma: study protocol of the phase I HYDRA trial. BMC Cancer, 23(1), 1–8. https://doi.org/10.1186/s12885-023-11031-w
Chicago
Elbers, Joris B. W., Pascal A. Gunsch, Reno Debets, Stijn Keereweer, Esther van Meerten, Jaap Zindler, Yvette van Norden, et al. 2023. “HYpofractionated, Dose-Redistributed RAdiotherapy with Protons and Photons to Combat Radiation-Induced Immunosuppression in Head and Neck Squamous Cell Carcinoma: Study Protocol of the Phase I HYDRA Trial.” BMC Cancer 23 (1): 1–8. doi:10.1186/s12885-023-11031-w.